A Serum Resistant Polymer with Exceptional Endosomal Escape and mRNA Delivery Efficacy for CRISPR Gene Therapy
Advanced Science · 2025-04 · 12 (13)
DOI: 10.1002/advs.202413006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 08.02.2025. Verfasst von Jia Lv und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East Ch…. Hauptthemen laut MEDLINE: RNA, Messenger, Genetic Therapy, CRISPR-Cas Systems, Endosomes. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Nanoparticle‐based mRNA delivery offers a versatile platform for innovative therapies. However, most of the current delivery systems are limited by poor serum tolerance, suboptimal endosomal escape and mRNA delivery efficacy. Herein, a highly efficient mRNA‐delivering material is identified from a library of fluoropolymers. The lead material FD17 shows exceptional serum stability and endosomal escape, enabling efficient mRNA delivery into various cell types, surpassing commercial mRNA delivery reagents such as Lipofectamine 3000. The formed mRNA nanoparticles adsorb abundant serum albumin on the surface, which facilitates cellular uptake via scavenger receptor‐mediated endocytosis. FD17 enables the delivery of mRNAs encoding CRE, Cas9, and base editor hyCBE for efficient genome editing. The material mediates CRISPR/Cas9 gene therapy via intraocular injection effectively down‐regulates vascular endothelial growth factor A in retinal pigment epithelial cells of mice, yielding promising therapeutic responses against laser‐induced choroidal neovascularization. The discovered material in this study shows great promise for the development of mRNA therapeutics to combat a wide range of diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai, 200241, China.
- Department of General Surgery, Center for Metabolism Research, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, International School of Medicine, International Institutes of Medicine, Zhejiang U…
- Department of Ophthalmology and Vision Science, Eye, Ear, Nose, and Throat Hospital, Fudan University, Shanghai, 200030, China.
- Department of Ophthalmology, Eye & ENT Hospital, State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai, 200031, China.
- NHC Key laboratory of Myopia and Related Eye Diseases, Shanghai, 200031, China.
- Shanghai Engineering Research Center of Synthetic Immunology, Shanghai, 200032, China.
ORCID-Profile: Jia Lv, Yiyun Cheng
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Shanghai Medical Innovation Research Program
Zitieren
APA
Lv, J., Fan, Q., Zhang, Y., Zhou, X., Yu, P., Yu, X., Xin, C., Hong, J., & Cheng, Y. (2025). A Serum Resistant Polymer with Exceptional Endosomal Escape and mRNA Delivery Efficacy for CRISPR Gene Therapy. Advanced Science, 12(13). https://doi.org/10.1002/advs.202413006
Vancouver
Lv J, Fan Q, Zhang Y, Zhou X, Yu P, Yu X, et al. A Serum Resistant Polymer with Exceptional Endosomal Escape and mRNA Delivery Efficacy for CRISPR Gene Therapy. Advanced Science. 2025;12(13). doi:10.1002/advs.202413006
BibTeX
@article{Lv2025,
author = {Lv, Jia and Fan, Qianqian and Zhang, Yirou and Zhou, Xujiao and Yu, Panting and Yu, Xin and Xin, Changchang and Hong, Jiaxu and Cheng, Yiyun},
title = {A Serum Resistant Polymer with Exceptional Endosomal Escape and mRNA Delivery Efficacy for CRISPR Gene Therapy},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {13},
doi = {10.1002/advs.202413006}
}
EUVIMED